Grifols signs $4.8bn transatlantic loan refi with big term loan 'B'
Spanish pharmaceuticals company Grifols has completed the jumbo refinancing of $4.8bn-equivalent of transatlantic loans.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts